Literature DB >> 24985166

Mini-retroperitoneoscopic adrenalectomy: our experience after 50 procedures.

Francesco Porpiglia1, Cristian Fiori2, Riccardo Bertolo2, Giovanni Cattaneo2, Daniele Amparore2, Ivano Morra2, Michele Didio2, Stefano De Luca2, Roberto M Scarpa2.   

Abstract

OBJECTIVE: To present our experience with retroperitoneoscopic adrenalectomy using 3-mm instruments (mini-rA) for adrenal tumors.
MATERIALS AND METHODS: From March 2009 to May 2013, patients with adrenal tumors <6 cm in size and body mass index ≤ 35 were involved in this prospective study and underwent mini-rA performed by 3-mm instruments. Demographic, endocrine and perioperative data, and cosmetic results (using Patient Scar Assessment Questionnaire and Scoring System) were recorded and analyzed.
RESULTS: Fifty procedures were performed in 48 patients. All procedures were performed with neither conversion to open surgery nor reoperation or mortality. Median operative time and blood loss were 90 minutes (range, 45-210 minutes) and 50 mL (range, 20-210 mL), respectively. Only 1 intraoperative complication (2%) was recorded. Conversion to conventional laparoscopy was needed in 4 procedures (8%). Postoperative complications were recorded in 6 cases (Clavien grade ≤ 2). No differences were recorded in terms of perioperative variables when comparing procedures performed in patients having secreting tumors (n = 18) with other ones (n = 32). On the contrary, procedures performed in patients having benign lesions (n = 41) had significantly lower operative times and complications with respect to those performed in patients with malignant lesions (n = 9). Median Patient Scar Assessment Questionnaire score was 30 (minimum score 28 = the best result; maximum score = 112, the worst result).
CONCLUSION: In selected population, mini-rA is a feasible, safe, and effective technique in the treatment of adrenal masses <6 cm in size, offering objectively proven excellent patients' satisfaction with symptoms and cosmesis. Significant experience before embarking in this kind of surgery is recommended.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24985166     DOI: 10.1016/j.urology.2014.04.040

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Laparoscopic resection of giant adrenal malignant tumors, a case series and review of the literature.

Authors:  Konstantinos Sapalidis; Christoforos Kosmidis; Dimitrios Giannakidis; Varvara Fyntanidou; Anastasios Barmpas; Paul Zarogoulidis; Athanasios Katsaounis; Charilaos Koulouris; Nikolaos Michalopoulos; Aikaterini Amaniti; Zoi Aidoni; Stelian Mogoanta; Michael Karanikas; Panagoula Oikonomou; Konstantinos Romanidis; Anastasios Vagionas; Alexandru Marian Goganau; Alexandru Munteanu; Valeriou Surlin; Isaak Kesisoglou
Journal:  AME Case Rep       Date:  2020-01-20

Review 2.  Laparoscopic Adrenalectomy for Large Adrenocortical Carcinoma.

Authors:  Norman Oneil Machado; Hani Al Qadhi; Khalifa Al Wahaibi; Syed G Rizvi
Journal:  JSLS       Date:  2015 Jul-Sep       Impact factor: 2.172

3.  An update of posterior retroperitoneoscopic adrenalectomy - Case series.

Authors:  Carlos E Costa Almeida; Teresa Caroço; Marta A Silva; José M Baião; Ana Costa; Miguel N Albano; João M Louro; Luis F Carvalho
Journal:  Int J Surg Case Rep       Date:  2020-05-16

4.  Perioperative complications of adrenalectomy - 12 years of experience from a single center/teaching hospital and literature review.

Authors:  Michał Aporowicz; Paweł Domosławski; Piotr Czopnik; Krzysztof Sutkowski; Krzysztof Kaliszewski
Journal:  Arch Med Sci       Date:  2018-07-20       Impact factor: 3.318

5.  Posterior retroperitoneoscopic adrenalectomy-Case series.

Authors:  Carlos E Costa Almeida; Teresa Caroço; Marta A Silva; Miguel N Albano; João M Louro; Luis F Carvalho; Carlos M Costa Almeida
Journal:  Int J Surg Case Rep       Date:  2018-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.